HOME >> BIOLOGY >> NEWS
Project to make smallpox inoculations safe by 'leashing' current vaccine virus

Smallpox is one of humanity's oldest horrors and is still one of our greatest menaces, but, paradoxically, it is fear itself that keeps us from protecting ourselves against it.

We live in fear of a potentially devastating release of the virus by terrorists because our current smallpox vaccine, though very effective in providing immunity, relies on using the live vaccinia (once called "cowpox") virus that is itself deadly dangerous to small percentage of the people that would be vaccinated. Though mass vaccination would make us safe from this greatest of all bioterrors, the risks and the real cost in human lives has kept us from taking this step.

Arizona State University virologist Bertram Jacobs thinks he may have a way to end the worry. Jacobs has received a $5.5 million, five-year grant from the National Institutes of Health's Biodefense Partnership program to develop and test a modified smallpox vaccine that is expected to be identical in effectiveness to the current vaccine while being "treatable" for dangerous reactions.

Jacobs' partners in the grant are Dr. Jeffrey Jacobson at New York's Beth Israel Hospital and NYU; Dr. Alfred Prince, Dr. Mohamed Tarek Shata and Linda Andrus at the New York Blood Center; and Virax Holdings Limited, an Australian biomedical corporation. ASU will develop the modified vaccinia virus and do preliminary animal testing; Virax will create a clinical-grade vaccine from ASU stocks; the New York Blood Center and Beth Israel Hospital will do further animal testing and then human clinical trials.

The project aims to sidestep a problem that has prevented weaker, less dangerous vaccinia strains from being used as smallpox vaccines: they can not be tested for effectiveness because smallpox no longer exists in human populations and exposing humans to it for testing is too dangerous and morally unacceptable.

"The problem with making a safer vaccine is that you have to prove that it works, and you can
'"/>

Contact: James Hathaway
Hathaway@asu.edu
480-965-6375
Arizona State University
29-Sep-2003


Page: 1 2 3

Related biology news :

1. Virginia Tech researchers to release findings on Smith River Project
2. Tools from the Human Genome Project reveal a versatile microbe
3. Francis Collins and Ari Patrinos receive Energy Secretarys Gold Award for Human Genome Project
4. Project BioShield: Consistent financing, markets, indemnity for biodefense vaccine developers needed
5. AAAS Science Project/Unisys prize encourages student-led scientific inquiry on flight to soar
6. UT Southwestern named one of 10 NIH centers for Human Proteome Project
7. NSF awards $4.3 million to Rutgers for Maize Genome Sequencing Project
8. Moffitt Cancer Center receives DoD funds to establish National Functional Genomics Project
9. Darwins letters being sent to Galapagos Islands as part of Darwin Correspondence Project
10. Ames chemist wins national award for contributions to Human Genome Project
11. Virginia Tech researchers join NSF Arabidopsis 2010 Project; may help produce plants that defend themselves without pesticides

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, ... contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) ... develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to ...
(Date:7/22/2020)... ... July 21, 2020 , ... ... in technology and compliance, announces a new solution to manage regulated workloads on ... layer of their technology stack complies with FDA and global regulations. USDM's new ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... Commercial launch ... on pharma’s ability to discover a COVID cure or vaccine, the global economic downturn ... and price pressure is not going away and capturing full value from every product ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... , ... July 09, 2020 , ... ... 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining ... research team led by Dr MA has been using the zebrafish model to ...
(Date:7/7/2020)... ... , ... Bio-IT World has announced the winners of the ... of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance were honored. ... examples of how technology innovations and strategic initiatives can be powerful forces for ...
(Date:7/1/2020)... ... June 30, 2020 , ... Flagship ... of a new clinical diagnostics immuno-oncology service, TissueInsight . TissueInsight provides ... “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists in ...
(Date:6/28/2020)... , ... June 25, 2020 , ... ... advance photodynamic therapy for treating cancer, today announced the company has entered a ... Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual ...
Breaking Biology Technology:
Cached News: